Author： Hoffmeister Michael Chang-Claude Jenny Brenner Hermann
Publisher： Adis International
ISSN： 1170-229X
Source： Drugs & Aging, Vol.23, Iss.6, 2006-01, pp. : 513-523
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
NSAIDs reduce risk of prostate cancer?
Inpharma, Vol. 1, Iss. 1335, 2002-01 ,pp. :
Access to resources
Recommend
CT colonography: cost-effective screening for colorectal cancer?
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 603, 2010-01 ,pp. :
Oxaliplatin + fluorouracil the new standard in colorectal cancer?
Inpharma, Vol. 1, Iss. 1521, 2006-01 ,pp. :
Do antiandrogens improve survival in prostate cancer?
Inpharma, Vol. 1, Iss. 1236, 2000-01 ,pp. :
Reduced risk of colorectal adenoma recurrence with calcium?
Inpharma, Vol. 1, Iss. 1260, 2000-01 ,pp. :